operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full

Page 93

AstraZeneca Preparation of doses The AstraZeneca COVID-19 Vaccine does not need to be diluted, please follow the instructions provided by IMAC. These instructions are included in vaccine shipments and available on the IMAC website. Note: These instructions are regularly updated. Please ensure you are using the most recent version. Each multi-dose vial contains 10 doses of 0.5mL. Once the vial is opened/punctured the AstraZeneca Vaccine can be stored at 2°C-8°C and must be used within 48 hours. Opened/punctured vials must be returned to the fridge. Any vaccine not used within this time period must be discarded. Vaccines should be prepared as close to administration as possible, ideally as needed. If multiple vaccines are needed, there is an option to draw up several doses from the vial, but they must be used within 5 hours and can be stored either in the fridge or at room temp (max. of 30°C). Any vaccine not used within this time period must be discarded. The AstraZeneca vaccine is fragile and must not be shaken during preparation. The AstraZeneca vaccine does not need to be at room temperature prior to administration. Some liquid may remain in the vial after withdrawing the final dose. The leftover vaccine must be discarded. If during the preparation of the vaccine a foreign body (such as a black particle) or discolouration is identified, the vial should be discarded and recorded as an open vialquality issue in CIR. Before preparation check: •

it is the right vaccine

manufacturer’s vaccine expiry date

Number the vaccine vial and enter the number into the vaccine log. Second person also checks that the correct vaccine has been selected, by confirming the product name on the vial and checking the expiry date printed on vial by manufacturer. Second person also checks the numbering of the vial and documents these checks by signing/initialling the vaccine log. For quality and safety purposes, it is recommended that each vial and/or syringes (made from that vial), are labelled with the: •

date and time

expiry time

Version 33.0 Page 93


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Document version control

2min
pages 155-156

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 153-154

Appendix J: Risk mitigations for vaccination sites

2min
page 152

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 140-141

Appendix D: Logistics and inventory management

1min
page 139

Appendix G: Vaccination site screening questions

1min
page 143

Variations

1min
page 126

Incidents

6min
pages 121-125

National Immunisation Booking System

11min
pages 115-120

Affected persons under the Vaccinations Order

4min
pages 112-114

COVID-19 Trial Vaccinations

1min
page 111

Home vaccinations

2min
pages 109-110

Mobile vaccination team

1min
page 108

Vaccination in Hospital

1min
page 107

Vaccination and Surveillance Testing

1min
page 106

Vaccination in high-risk or screened ‘positive’ consumers

4min
pages 102-104

Third primary dose for severely immunocompromised

1min
page 105

Section E: Additional programme guidance, variations and incidents

1min
page 101

AstraZeneca Vaccine administration and observation

7min
pages 95-100

AstraZeneca Preparation of doses

2min
pages 93-94

AstraZeneca Operational phase

1min
page 92

Booking and scheduling

1min
page 91

Section D: AstraZeneca COVID-19 Vaccine

1min
page 90

Paediatric Pfizer Vaccine administration and observation

8min
pages 85-89

Paediatric Pfizer Preparation of doses

3min
pages 82-84

Pfizer Vaccine administration and observation

12min
pages 69-77

Pfizer Preparation of doses

4min
pages 66-68

Pfizer Operational phase

2min
pages 63-64

Protecting security and privacy

1min
page 62

Vaccinating consumers aged 12 to 15 years

1min
page 65

Booking and scheduling

2min
pages 60-61

Becoming a COVID-19 Vaccination site

1min
page 58

Site readiness and closure

1min
page 57

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 55-56

COVID-19 Immunisation Register

3min
pages 27-29

Logistics

1min
page 30

Vaccine storage and handling

7min
pages 37-42

Infection prevention and control (IPC

2min
pages 25-26

Preparing the vaccination workforce

7min
pages 20-24

Equipment ordering and demand planning

7min
pages 31-36

Site considerations

7min
pages 16-19

Section A: Ready to vaccinate

1min
page 13
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full by WBOP PHO - Issuu